Futibatinib, also known as LYTGOBI, is a specific drug for bile duct diseases. It achieves the purpose of treatment by inhibiting the activity of FGFR and blocking the signal transduction of diseased cells. So, how to use futibatinib (LYTGOBI)?

How to use futibatinib (LYTGOBI)?

Futibatinib is a targeted drug for bile duct diseases. The following is a detailed description of its use:

Usage and dosage

The recommended dose of futibatinib is 20mg per day, taken orally once a day. Patients should take futibatinib at approximately the same time every day to maintain a stable concentration of the drug in the body. Futibatinib tablets should be swallowed whole and should not be crushed, chewed, split or dissolved. To ensure the normal release and absorption of the drug in the body.

Missed and supplementary doses

If a patient misses a dose of futibatinib and the missed time exceeds 12 hours, or vomiting occurs, the dose should be re-administered at the next scheduled dose instead of supplementing the missed dose. This is to avoid excessive accumulation of drugs in the body, leading to adverse reactions.

Following the above usage method can ensure the effectiveness of Futibatinib. If you have any questions or discomfort, please consult a doctor in time.

Futibatinib (LYTGOBI) precautions

Patients need to pay attention to the following matters during the use of Futibatinib (LYTGOBI):

Treatment course

Futibatinib treatment should continue until the disease progresses or unacceptable toxicity occurs. The doctor will decide whether to continue treatment based on the patient's specific situation and efficacy evaluation.

Monitoring

During Futibatinib treatment, patients should undergo regular comprehensive physical examinations and evaluations, including ophthalmological examinations, blood phosphorus level monitoring, etc., so as to promptly detect and deal with possible adverse reactions and complications.

Drug storage

Futibatinib should be stored at room temperature of 20~25℃, and kept dry and away from light. Avoid exposing the drug to high temperature, humidity or direct sunlight. The shelf life of Futibatinib is usually 24 months, and the specific shelf life may vary from batch to batch. Patients should check the expiration date information on the drug packaging before use and use it within the expiration date.

Futibatinib is an effective targeted drug for bile duct disease, and it is necessary to strictly follow the doctor's instructions and precautions during use. Patients should undergo regular physical examinations and evaluations to promptly detect and deal with possible adverse reactions and complications. Attention should also be paid to the storage and expiration date information of the drug to ensure the effectiveness of the drug.